Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Jacobs Engineering Group Inc ( JEC - Analyst Report ) reported strong fiscal fourth-quarter and full year 2012 (ending September 28, 2012) financial results. Though earnings came in better than expected, both the quarter’s and fiscal 2012 revenues fell short of the Zacks Consensus Estimate.
The company reported fourth quarter earnings per share of 83 cents, beating the Zacks Consensus Estimate of 80 cents. The quarterly earnings also improved 12.2% from the year-ago earnings of 74 cents a share.
Fiscal 2012 earnings came in at $2.94 per share, beating the Zacks Consensus Estimate of $2.91 by 1%. Earnings for fiscal 2012 also increased from the 2011 earnings of $2.60 by 13%.
The company generated a one-time gain of $6.3 million on sale of its intellectual property for iron ore palletizing and other related assets. Excluding this impact, the company’s non-GAAP earnings in the reported quarter were 80 cents, whereas earnings in fiscal 2012 were $2.91, both in line with the Zacks Consensus Estimate.
Revenue
Revenue increased 2.6% year over year to $2.72 billion in the reported quarter. However, it fell short of the Zacks Consensus Estimate of $2.87 billion by 5.7%. Revenue for fiscal 2012 came in at $10.89 billion, an increase of 4.91% compared with 2011. It was 0.9% lower than the Zacks Consensus Estimate of $10.99 billion.
Technical Professional Services revenue came in at $1.63 billion, increasing 2.24% from the year-ago quarter. However, the segment’s revenue increased 9.8% to $6.46 billion in fiscal 2012.
Field Services revenue in fourth quarter was $1.15 billion, up 2.4% from fourth quarter 2011. However, revenue in fiscal 2012 slipped 1.5% from fiscal 2011 to $4.43 billion.
Costs
During the reported quarter, direct costs of contracts, a major expenditure for Jacobs, edged up 1.86% from the year-ago quarter to settle at $2,339.6 million. Selling, general and administrative (SG&A) expenses came in at $279.0 million, up 0.13% year over year.
Operating profit improved to $167.6 million, an increase of 13.3% over the year-ago quarter.
Backlog
Exiting the fourth quarter, backlog stood at $15.9 billion, an increase of 11.3% from $14.3 billion in the year-ago quarter. It includes backlog from technical professional services of $10.3 billion versus $9.1 billion at the end of the fourth quarter of 2011.
The company has won a number of contracts in the quarter, including contracts to support NASA Marshall Space Flight Center (on July 24, 2012, worth $600 million), a contract from CODELCO to provide engineering services for a copper mine in Chile (on August 8, 2012, estimated total installed cost $4.5 billion) and contract from Methanex to provide engineering, procurement and construction services in Louisiana (on August 14, 2012, worth $550 million), among others.
Balance Sheet
Jacobs’ cash and cash equivalents at the end of fourth quarter were approximately $1,032 million, up 14.0% year over year. Total debt decreased 7.5% from the previous-year quarter to $528.3 million as of September 28, 2012.
Outlook
Based on improvement across most markets, encouraging backlog, increased margins and a stronger balance sheet, Jacobs expects earnings for fiscal 2013 between $3.00 and $3.50 per share. Improved earnings in 2012 also allowed management initiate the fiscal 2013 guidance.
The company competes against industry players including Fluor Corporation ( FLR - Analyst Report ) and Foster Wheeler AG ( FWLT - Analyst Report ) . We currently maintain a Neutral recommendation on Jacobs. The stock also bears a Zacks #3 Rank, which implies a short-term (1-3 months) Hold rating.
Read the full reports :
Analyst Report on JEC
Analyst Report on FWLT
Analyst Report on FLR